Drugplain

acamprosate calcium 333 mg/1

acamprosate calcium · TABLET, DELAYED RELEASE · Zydus Pharmaceuticals (USA) Inc.

No Recall History
Plain English

acamprosate calcium is a tablet, delayed release containing acamprosate calcium at 333 mg/1, taken oral. Manufactured by Zydus Pharmaceuticals (USA) Inc..

Key Facts

Brand Name
acamprosate calcium
Generic Name
acamprosate calcium
NDC Code (Product)
68382-569
Manufacturer
Zydus Pharmaceuticals (USA) Inc.
Strength
333 mg/1
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA205995
Marketing Start
06/01/2017

Recall History

No Recall History

Frequently Asked Questions

What is acamprosate calcium used for?

acamprosate calcium contains acamprosate calcium. It is a tablet, delayed release taken oral. Consult your doctor for specific uses.

Is acamprosate calcium a controlled substance?

acamprosate calcium is not classified as a controlled substance by the DEA.

What is the generic name for acamprosate calcium?

The generic name for acamprosate calcium is acamprosate calcium. There are 6 other brand versions of acamprosate calcium.

What is the NDC code for acamprosate calcium 333 mg/1?

The NDC (National Drug Code) for acamprosate calcium 333 mg/1 is 68382-569, listed by Zydus Pharmaceuticals (USA) Inc..

Product NDC

68382-569

Package NDC

68382-569-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)